PAUL MONAHAN, MD
Medical Practice at Manning Dr, Chapel Hill, NC
License number
North Carolina 0096-01534
Category
Medical Practice
Type
Pediatric Hematology-Oncology
Address
Address
101 Manning Dr, Chapel Hill, NC 27599
Phone
(919) 966-4131
Personal information
See more information about PAUL MONAHAN at radaris.comName
Address
Phone
23 East Dr, Chapel Hill, NC 27516
Organization information
See more information about PAUL MONAHAN at bizstanding.comPaul Monahan MD
101 Manning Dr, Chapel Hill, NC 27514
Industry:
Pediatric Oncologist
Phone:
(919) 843-6687 (Phone)
Paul Edward Monahan Ii
Unc Clinic - Paul Monahan MD
101 Manning Dr #7001J, Chapel Hill, NC 27514
Categories:
Hematology Physicians & Surgeons, Oncology Physicians & Surgeons, Pediatrics Physicians & Surgeons, ...
Phone:
(919) 966-7890 (Phone)
Professional information
Dr. Paul E Monahan, Chapel Hill NC - MD (Doctor of Medicine)
Specialties:
Pediatric Hematology & Oncology
Address:
101 Manning Dr, Chapel Hill 27514
(919) 966-4131 (Phone), (919) 843-5515 (Fax)
1185 Physicians Office, Chapel Hill 27599
(919) 966-4131 (Phone), (919) 843-5515 (Fax)
1185 Physicians Office, Chapel Hill 27599
Certifications:
Pediatric Oncology & Pediatric Hematology, 1996, Pediatrics, 1995
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
101 Manning Dr, Chapel Hill 27514
1185 Physicians Office, Chapel Hill 27599
University of North Carolina Hospital
101 Manning Dr, Chapel Hill 27514
1185 Physicians Office, Chapel Hill 27599
University of North Carolina Hospital
101 Manning Dr, Chapel Hill 27514
Education:
Medical School
University of Virginia / Main Campus
Graduated: 1990
University Of Nc Hosps
University of Virginia / Main Campus
Graduated: 1990
University Of Nc Hosps
Paul E Monahan, Chapel Hill NC
Specialties:
Pediatric Hematologist / Oncologist
Address:
101 Manning Dr, Chapel Hill, NC 27514
Board certifications:
American Board of Pediatrics Sub-certificate in Pediatric Hematology/Oncology (Pediatrics)
Methods And Compositions For Intra-Articular Coagulation Proteins
US Patent:
2010013, Jun 3, 2010
Filed:
Apr 11, 2008
Appl. No.:
12/595308
Inventors:
Paul E. Monahan - Chapel Hill NC, US
Richard Jude Samulski - Chapel Hill NC, US
Darrel W. Stafford - Carrboro NC, US
Richard Jude Samulski - Chapel Hill NC, US
Darrel W. Stafford - Carrboro NC, US
International Classification:
A61K 38/37, A61K 38/00, A61K 31/7088, A61K 38/36, A61K 38/19
US Classification:
514 12, 514 2, 514 44 R
Abstract:
The present invention provides methods and compositions for treating blood clotting factor disorders and/or reducing bleeding-associated joint damage by treatments delivered to the joint in a subject.
Compositions And Methods For Enhanced Parvovirus Transduction
US Patent:
2013001, Jan 10, 2013
Filed:
Feb 4, 2011
Appl. No.:
13/575975
Inventors:
Paul E. Monahan - Chapel Hill NC, US
Richard Jude Samulski - Chapel Hill NC, US
Richard Jude Samulski - Chapel Hill NC, US
International Classification:
A61K 31/7088, A61P 7/04, C12N 15/861
US Classification:
514 44 R, 435456
Abstract:
The present invention provides methods and compositions for enhanced transduction of an adeno-associated virus (AAV) vector comprising a heterologous nucleic acid of interest wherein the AAV vector genome is oversized relative to a wild type AAV genome by employing a proteasome inhibitor.
Methods And Compounds For Controlled Release Of Recombinant Parvovirus Vectors
US Patent:
7923436, Apr 12, 2011
Filed:
Apr 5, 2007
Appl. No.:
11/697194
Inventors:
Paul E. Monahan - Chapel Hill NC, US
Richard Jude Samulski - Chapel Hill NC, US
Joseph E. Rabinowitz - Carrboro NC, US
Richard Jude Samulski - Chapel Hill NC, US
Joseph E. Rabinowitz - Carrboro NC, US
Assignee:
University of North Carolina - Chapel Hill - Chapel Hill NC
International Classification:
A61K 48/00, A61K 39/23
US Classification:
514 44R, 4242331
Abstract:
The invention uses recombinant parvoviruses, and particularly recombinant adeno-associated virus (rAAV) to deliver genes and DNA sequences for gene therapy following manipulation of the therapeutic virus for packaging and transport. The invention delivers therapeutic viral vectors via rAAV affixed to support matrixes (i. e. , sutures, surgically implantable materials, grafts, and the like).
Methods And Compounds For Controlled Release Of Recombinant Parvovirus Vectors
US Patent:
2004001, Jan 22, 2004
Filed:
Dec 19, 2002
Appl. No.:
10/276501
Inventors:
Paul Monahan - Chapel Hill NC, US
Richard Samulski - Chapel Hill NC, US
Joseph Rabinowitz - Carrboro NC, US
Richard Samulski - Chapel Hill NC, US
Joseph Rabinowitz - Carrboro NC, US
International Classification:
A61K048/00, C12N015/86
US Classification:
424/093200, 435/456000
Abstract:
The invention uses recombinant parvoviruses, and particularly recombinant adeno-associated virus (rAAV) to deliver genes and DNA sequences for gene therapy following manipulation of the therapeutic virus for packaging and transport. The invention delivers therapeutic viral vectors via rAAV affixed to support matrixes (i.e., sutures, surgically implantable materials, grafts, and the like).